Explore 3 Stock Ideas & Industry Insights Download Free Report

Kraig Biocraft Labs

Company price
0.0825 USD 0.00(0%)
Last update at 2026-11-13T20:51:00Z
VOLUME
81709
Market Cap
50.64M

Momentum Score

…

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.08
Low
0.08
High
52 Week Price Range
0.03
Low
0.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Kraig Biocraft Labs develops genetically engineered spider silk fibers produced via transgenic silkworms for textile and industrial uses. Long-term growth may be driven by successful manufacturing scale-up, commercialization or licensing, and demand for sustainable, high-strength materials. The company may attract investors due to its proprietary technology and potential exposure to specialty fiber markets.

Material risks include early-stage commercialization, uncertain market adoption, manufacturing scale-up and significant financing and execution risk given limited operating history.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.08
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
1.19M
ROCE
60.59%
Diluted EPS TTM
-

Insight Announcement

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -3.84M -8.05M -4.97M -2.91M -1.17M
Minority interest - - - - 0.00M
Net income -3.84M -8.05M -4.97M -2.91M -1.17M
Selling general administrative 1.94M 2.56M 4.45M 2.40M 1.21M
Gross profit - - - - 0.40M
Reconciled depreciation 0.03M 0.04M 0.03M 0.03M 0.03M
Ebit -2.12M -2.76M -4.53M -2.62M -0.96M
Ebitda -3.20M -2.64M -4.56M -2.58M -0.91M
Non operating income net other - - - - 0.00M
Operating income -2.12M -2.76M -4.53M -2.62M -0.96M
Other operating expenses - - - - 0.00M
Interest expense 0.61M 0.66M 0.39M 0.29M 0.23M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income - - 0.00M 0.01M -
Net interest income -1.72M -5.36M -0.44M -0.29M -0.23M
Extraordinary items - - - - 0.00M
Non recurring - - - - 0.00M
Other items - - - - 0.00M
Income tax expense - - - - 0.00M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.40M
Total operating expenses 2.12M 2.76M 4.53M 2.62M 1.36M
Cost of revenue - - - - 0.00M
Total other income expense net 0.00M 0.08M - - 0.02M
Discontinued operations - - - - 0.00M
Net income from continuing ops -3.84M -8.05M -4.97M -2.91M -1.17M
Net income applicable to common shares -3.84M -8.05M -4.97M -2.91M -1.17M
Preferred stock and other adjustments - - - - 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 4.57M 3.02M 1.28M 0.75M 0.07M
Intangible assets - - - - 0.00M
Other current assets - - - - 0.00M
Total liab 8.09M 8.32M 7.85M 6.14M 4.53M
Total stockholder equity -3.52M -5.30M -6.57M -5.39M -4.46M
Deferred long term liab - - - - 0.00M
Other current liab - 0.35M 0.33M 0.30M 0.25M
Common stock 27.06M 22.39M 17.12M 16.76M 15.15M
Capital stock 32.28M 27.60M 22.34M 21.97M 20.36M
Retained earnings -46.66M -42.81M -34.77M -29.80M -26.89M
Other liab - - - - 0.00M
Good will - - - - 0.00M
Other assets 0.00M 0.00M 0.00M 0.00M 0.00M
Cash 3.86M 2.36M 0.82M 0.13M 0.01M
Total current liabilities 8.07M 8.16M 7.45M 5.58M 4.53M
Net debt - - 1.19M 0.76M 0.31M
Short term debt - - - 0.70M 0.00M
Short long term debt 1.71M 2.22M 1.86M 0.70M 0.32M
Other stockholder equity 0.02M 0.02M 0.02M 0.02M 0.02M
Property plant equipment 0.15M 0.22M 0.45M 0.59M 0.05M
Total current assets 3.98M 2.37M 0.82M 0.16M 0.02M
Long term investments 0.44M 0.44M - - 0.00M
Net tangible assets -8.74M -10.51M -11.79M -10.61M -9.68M
Short term investments - - - - 0.00M
Net receivables - - - - 0.00M
Long term debt - 0.10M 0.15M 0.19M 0.00M
Inventory 0.01M - - - 0.00M
Accounts payable 0.54M 3.65M 3.43M 3.16M 0.79M
Total permanent equity - - - - 0.00M
Noncontrolling interest in consolidated entity - - - - 0.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00M
Accumulated other comprehensive income - - - - 0.00M
Additional paid in capital - - - - 0.00M
Common stock total equity - - - - 0.00M
Preferred stock total equity - - - - 0.00M
Retained earnings total equity - - - - 0.00M
Treasury stock - - - - 0.00M
Accumulated amortization - - - - 0.00M
Non currrent assets other - - - 0.59M 0.05M
Deferred long term asset charges - - - - 0.00M
Non current assets total 0.59M 0.66M 0.46M 0.59M 0.05M
Capital lease obligations 0.06M 0.10M 0.38M 0.48M 0.00M
Long term debt total - - - - 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.01M -0.45M -0.45M -0.45M -0.45M
Change to liabilities 0.14M 0.20M 0.04M 0.31M 0.14M
Total cashflows from investing activities -0.01M -0.55M -0.55M -0.10M -0.01M
Net borrowings 2.66M 3.62M 2.02M 0.30M 0.24M
Total cash from financing activities 3.40M 3.89M 1.95M 1.30M 0.24M
Change to operating activities 0.37M 0.42M 0.69M 0.78M 0.68M
Net income -3.84M -8.05M -4.97M -2.91M -1.17M
Change in cash 1.51M 1.54M 0.69M 0.11M -0.00M
Begin period cash flow 2.36M 0.82M 0.13M 0.01M 0.02M
End period cash flow 3.86M 2.36M 0.82M 0.13M 0.01M
Total cash from operating activities -1.89M -1.80M -1.25M -1.09M -0.24M
Issuance of capital stock - 0.00M 0.02M 1.00M 0.00M
Depreciation 0.03M 0.03M 0.03M 0.03M 0.03M
Other cashflows from investing activities - - - - 0.00M
Dividends paid - - - - 0.00M
Change to inventory -0.01M -0.01M -0.01M -0.01M 0.00M
Change to account receivables - - - 0.00M 0.03M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities - - -0.09M -0.09M -0.09M
Change to netincome 0.32M 0.90M 2.90M 0.70M 0.06M
Capital expenditures 0.01M 0.10M 0.10M 0.10M 0.01M
Change receivables - - - - 0.00M
Cash flows other operating - - - - 0.00M
Exchange rate changes - - - - 0.00M
Cash and cash equivalents changes - - - - 0.00M
Change in working capital 0.50M 0.62M 0.73M 1.09M 0.84M
Other non cash items 1.19M 5.03M 0.11M 0.00M 0.06M
Free cash flow -1.89M -1.90M -1.25M -1.19M -0.25M

Peer Comparison*

Sector: Basic Materials Industry: Specialty Chemicals

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
KBLB
Kraig Biocraft Labs
-
-%
0.08 - - 1199.03 - -21.22
LIN
Linde plc Ordinary Shares
3.57
0.68%
526.06 33.77 28.90 6.56 5.42 18.92
AIQUY
Air Liquide SA ADR
-0.02
0.05%
42.57 30.69 24.81 4.70 4.10 15.61
AIQUF
L'Air Liquide S.A
2.55
1.20%
214.85 29.78 22.68 4.54 3.98 15.90
SHW
Sherwin-Williams Co
-1.50
0.43%
349.89 33.33 27.40 3.38 20.60 21.36

Profile*

Kraig Biocraft Labs

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

2723 South State Street, Ann Arbor, MI, United States, 48104

734 619 8066

36

Name Title Year Born
Mr. Kim Kraig Thompson Founder, Chairman, CEO, Pres, CFO & Corp. Sec. 1961
Mr. Jonathan R. Rice Chief Operating Officer 1980
Mr. Kenneth Le Director of Gov. Relations & Pres of Prodigy Textiles 1966
Dr. Trevor L. Kane Chief Scientist & Member of Scientific Advisory Board NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…